Single dose 17 alpha-hydroxyprogesterone caproate in preterm labor: A randomized trial

Archives of Gynecology and Obstetrics

Volumn 285, Issue 3, 2012, Pages 585-590

  Tan, Peng Chiong ^a   King, Anthonia Siaw Jia ^a   Vallikkannu, Narayanan ^a   Omar, Siti Zawiah ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Preterm labor; Progesterone; Randomized trial; Tocolysis

Indexed keywords

DEXAMETHASONE; HYDROXYPROGESTERONE CAPROATE; NIFEDIPINE; PLACEBO; SODIUM CHLORIDE; 17-ALPHA-HYDROXY-PROGESTERONE CAPROATE; CORTICOSTEROID; GESTAGEN; PROGESTERONE DERIVATIVE; UTERUS SPASMOLYTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DELIVERY; DRUG DOSE TITRATION; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TOCOLYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; NEWBORN; PREGNANCY; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYPROGESTERONES; INFANT, NEWBORN; NIFEDIPINE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; PROGESTINS; TOCOLYTIC AGENTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84863193938     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-2026-3     Document Type: Article

References (27)

1. Muglia LJ, Katz M (2010) The enigma of spontaneous preterm birth. N Engl J Med 362(6):529-535.
2. Gibson AT (2007) Outcome following preterm birth. Best Pract Res Clin Obstet Gynaecol 21(5):869-882.
3. Swamy GK, Ostbye T, Skjaerven R (2008) Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth. JAMA 299(12):1429-1436.
4. Moster D, Lie RT, Markestad T (2008) Long-term medical and social consequences of preterm birth. N Engl J Med 359(3): 262-273.
5. Roberts D, Dalziel S (2006) Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 3:CD004454.
6. Waters TP, Mercer B (2009) Impact of timing of antenatal corticosteroid exposure on neonatal outcomes. J Matern Fetal Neonatal Med 22(4):311-314.
7. Antenatal corticosteroids to prevent respiratory distress syndrome. February 2004. Accessible online http://www.rcog.org.uk/files/rcog-corp/ GT7Antenatal Corticosterodsamended.pdf. Last accessed 8 June 2010.
8. The Royal College of Obstetricians and Gynaecologists, United Kingdom. Green Top Guideline No. 1(B). Tocolytic drugs for women in preterm labour. October 2002. Accessible online http://www.rcog.org.uk/files/rcog-corp/ GT1BTocolyticDrug2002revised.pdf. Last accessed 8 June 2010.
9. Lachelin GC, McGarrigle HH, Seed PT, Briley A, Shennan AH, Poston L (2009) Low saliva progesterone concentrations are associated with spontaneous early preterm labour (before 34 weeks of gestation) in women at increased risk of preterm delivery. BJOG 116(11):1515-1519.
10. Stamatelou F, Deligeoroglou E, Farmakides G, Creatsas G (2009) Abnormal progesterone and corticotropin releasing hormone levels are associated with preterm labour. Ann Acad Med Singapore 38(11):1011-1016.
11. Bell R (1983) Antenatal oestradiol and progesterone concentrations in patients subsequently having preterm labour. Br J Obstet Gynaecol 90(10):888-891.
12. Smit DA, Essed GG, de Haan J (1984) Predictive value of uterine contractility and the serum levels of progesterone and oestrogens with regard to preterm labour. Gynecol Obstet Invest 18(5): 252-263.
13. Dodd JM, Flenady VJ, Cincotta R, Crowther CA (2008) Progesterone for the prevention of preterm birth: a systematic review. Obstet Gynecol 112(1):127-134.
14. Su LL, Samuel M, Chong YS (2010) Progestational agents for treating threatened or established preterm labour. Cochrane Database Syst Rev (1):CD006770.
15. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW et al (2003) Prevention of recurrent preterm delivery by 17 alphahydroxyprogesterone caproate. N Engl J Med 348(24):2379-2385.
16. Zakar T, Mesiano S (2011) How does progesterone relax the uterus in pregnancy? N Engl J Med 364(10):972-973.
17. Renthal NE, Chen CC, Williams KC, Gerard RD, Prange-Kiel J, Mendelson CR (2010) miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci USA 107(48):20828-20833.
18. King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B (2003) Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev (1):CD002255.
19. Fuchs F, Stakemann G (1960) Treatment of threatened premature labor with large doses of progesterone. Am J Obstet Gynecol 79:172-176.
20. Erny R, Pigne A, Prouvost C, Gamerre M, Malet C, Serment H, Barrat J (1986) The effects of oral administration of progesterone for premature labor. Am J Obstet Gynecol 154(3):525-529.
21. Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A (2007) Cervical length changes during preterm cervical ripening: effects of 17-alpha- hydroxyprogesterone caproate. Am J Obstet Gynecol 196(5):453 (e1-4; discussion 421).
22. Noblot G, Audra P, Dargent D, Faguer B, Mellier G (1991) The use of micronized progesterone in the treatment of menace of preterm delivery. Eur J Obstet Gynecol Reprod Biol 40(3):203-209.
23. Facchinetti F, Dante G, Venturini P, Paganelli S, Volpe A (2008) 17alpha-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery. Am J Perinatol 25(8):503-506.
24. Borna S, Sahabi N (2008) Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial. Aust N Z J Obstet Gynaecol 48(1):58-63.
25. Ruddock NK, Shi SQ, Jain S, Moore G, Hankins GD, Romero R, Garfield RE (2008) Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions. Am J Obstet Gynecol 199(4):391 (e1-7).
26. Anderson L, Martin W, Higgins C, Nelson SM, Norman JE (2009) The effect of progesterone on myometrial contractility, potassium channels, and tocolytic efficacy. Reprod Sci 16(11):1052-1061.
27. O'Brien JM, Ho SJ, Istwan NB, Stanziano GJ, Rhea DJ, Barton JR (2010) Uterine activity in women receiving 17 alpha-hydroxyprogesterone caproate for the prevention of preterm birth: an observational study. Am J Perinatol 27(2):157-162